As the time of “sell in May and go away” arrived, it seems the short sellers were neither strongly for nor against the notion, as least as far as the most heavily…
The most shorted of Nasdaq stock, Sirius XM, bucked the trend with a sharp increase in the number of its shares short.
The largest decline among the top five most shorted Nasdaq stocks was in the shares of biopharmaceutical company MannKind. Intel’s short interest was essentially the same as at the end of March.
The interest in the five most heavily shorted stocks traded on the Nasdaq declined between the March 15 and March 31 settlement dates. Leading that trend was AMD.
Interest in the most heavily shorted stocks traded on the Nasdaq rose, for the most part, between the February 29 and March 15 settlement dates. Leading that trend was Intel.
Novavax reported disappointing fourth-quarter financial results before the markets opened on Monday.
Chris Lange When it came to the most heavily shorted stocks traded on the Nasdaq, short sellers appeared to be remain cautious.
On the close Tuesday, the PowerShares Dynamic exchange traded funds (ETFs) are set for a rebalance. These four stocks that are expected to have huge buying on the close Tuesday.
Novavax has announced positive top-line data from a Phase 2 clinical trial of its RSV F-protein recombinant nanoparticle vaccine candidate to protect infants via maternal immunization.
Chris Lange Despite the market falling on Tuesday, Novavax bucked the trend and was up handily, after a Phase 2 breakthrough with its RSV candidate.
Chris Lange Novavax is on the precipice of vaccinating Ebola, or at least according to its most recent clinical trial.
Chris Lange In a week that saw big up and down swings, insiders certainly do not look panicked to sell shares, and that is a positive.
With April coming to a close on Thursday, it is time for yet another rebalancing of some of the biggest indexes on Wall Street.
This past week we tracked seven key analyst calls with big upside in stocks that were trading under $10 when the analysts made their calls.
Jon C. Ogg Tuesday's top analyst upgrades and downgrades include American Express, BIND Therapeutics, Devon Energy, General Motors, Novavax and Toyota.
